Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Pharmacyclics LLC.
Pharmacyclics LLC.
National Cancer Institute (NCI)
SWOG Cancer Research Network
University of Chicago
University of Washington
National Institutes of Health Clinical Center (CC)
BeOne Medicines
BeOne Medicines
Espad Pharmed
Hope Biosciences Research Foundation
Fred Hutchinson Cancer Center
Gilead Sciences
Incyte Corporation
Acerta Pharma BV
Novartis
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
Thomas Jefferson University
Acerta Pharma BV
Novartis
National Cancer Institute (NCI)
City of Hope Medical Center
Universität des Saarlandes
Insel Gruppe AG, University Hospital Bern
University of Washington
Georgetown University
Celgene
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Eisai Inc.
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Mayo Clinic
Celgene
Ohio State University Comprehensive Cancer Center
CarboFix Orthopedics Ltd.
City of Hope Medical Center
AIDS Malignancy Consortium
Indivior Inc.
Incyte Corporation
Fred Hutchinson Cancer Center
Columbia University
Ipsen
Dana-Farber Cancer Institute
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Mayo Clinic